Announcement on Voluntary Disclosure of Approval of Clinical Trial Application for Adsorbed Acellular DTPa (Dual-component) Combined Vaccine (for Adults and Adolescents)

About this update from Changchun Bcht Biotechnology Co. Class A

Announcement on Voluntary Disclosure of Approval of Clinical Trial Application for Adsorbed Acellular DTPa (Dual-component) Combined Vaccine (for Adults and Adolescents)The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Changchun Bcht Biotechnology Co. Class A